Mel Med

Meloxicam, the active ingredient in Mel Med, is a NSAID (Oxicam) presented as a [strength]/[form] for oral use. It treats osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain and musculoskeletal pain in adults and children as appropriate.

GNH USA supplies Mel Med as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is indicated for inflammatory joint diseases and acute musculoskeletal pain. - Osteoarthritis: reduces joint pain and improves mobility in patients with degenerative joint disease. - Rheumatoid arthritis: alleviates inflammation and pain associated with chronic autoimmune arthritis. - Juvenile rheumatoid arthritis: provides symptom relief in pediatric patients with inflammatory arthritis. - Acute pain: offers rapid analgesia for short‑term painful conditions. - Musculoskeletal pain: eases pain from strains, sprains and other soft‑tissue injuries.

Adverse reactions may occur with meloxicam use.

Common Side Effects: - Dyspepsia: upset stomach or indigestion. - Nausea: feeling of sickness or urge to vomit. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness. - Peripheral edema: swelling of the lower limbs. - Hypertension: increase in blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: severe stomach or intestinal lesions. - Cardiovascular events: increased risk of heart attack or stroke. - Hepatic injury: signs of liver dysfunction such as jaundice. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal failure: sudden loss of kidney function. - Anaphylaxis: life‑threatening allergic reaction.

Before initiating meloxicam therapy, consider the following safety measures. - Renal function: monitor kidney parameters in patients with existing renal impairment. - Cardiovascular risk: use cautiously in individuals with a history of heart disease or stroke. - Gastrointestinal history: assess for prior ulcers or bleeding disorders. - Pregnancy and lactation: avoid unless the potential benefit outweighs the risk. - Concomitant medications: review use of other NSAIDs, anticoagulants, or corticosteroids. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Meloxicam can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective COX‑2 inhibitors: increased cardiovascular risk when combined.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may exacerbate renal impairment. - Lithium: meloxicam can raise serum lithium levels, requiring monitoring. - Methotrexate: potential for increased toxicity. - Cyclosporine: enhanced nephrotoxic risk.